5th Neuroblastoma Research Symposium, Cambridge, 11-12th April 2019
to Apr 12

5th Neuroblastoma Research Symposium, Cambridge, 11-12th April 2019

  • The Stephen Perse Foundation (map)
  • Google Calendar ICS

Neuroblastoma UK’s 5th Neuroblastoma Research Symposium will be held in Cambridge on 11-12th April at The Stephen Perse Foundation, Union Road, Cambridge, CB2 1HF, UK.

The Symposium is presented by Neuroblastoma UK and co-hosted by Prof. Anna Philpott (Dept. Oncology, University of Cambridge).

The Symposium is also supported by the Cancer Research UK Cambridge Centre programmes for Paediatrics and Neuro-Oncology.

We are also grateful to EUSA Pharma and Ergomed for meeting sponsorship.

The sponsoring companies have no involvement in the meeting content or selection of speakers.


A nominal registration fee of £100 will be charged, waived for Postgraduates. Attendance at the Symposium Dinner on the Thursday evening is included in Registration. Deadline for registration is 22nd March.


Abstracts are invited for 6 x 15 minute Submitted Talks, one per session, on any neuroblastoma-related topic. Deadline is now closed.

Poster abstracts are also invited on any neuroblastoma-related topic. Poster prizes, two each in basic, translational and clinical categories, will be awarded by a panel of experts at the end of the Symposium. Deadline 22nd March.

Please send abstracts of no more than 200 words in Word format to symposium@neuroblastoma.org.uk. Outside of the word limit, please include a title, names and affiliations of all authors, and a maximum of 2 paper citations.

Accommodation & Travel

The Stephen Perse Foundation, CB2 1HF, with entrance on Union Road, is in central Cambridge, about 10 minutes walk or a short taxi ride from the main Cambridge rail station.

For flights from Europe, London Stansted is by far the most convenient, with good train connections to Cambridge.

For overnight accommodation, in increasing price order, Travelodge Cambridge Central, Hotel Ibis Cambridge Central, University Arms Hotel and Hilton Cambridge City Centre are all well situated close to the train station and/or Symposium venue. Alternatively, University college rooms are let out in the University holidays, which might appeal for a college experience - options are quite varied.


Thursday 11th April

12:00 – 13:00 Registration, lunch & poster setup

13:00 – 13:10 Introduction

Session 1: Neuroblastoma biology & prognosis

Cancer Research UK Cambridge Centre Neuro-oncology Programme Session

13:10 – 13:40 Sandra Ackermann (Cologne): The genetic basis of favourable outcome and fatal tumour progression in neuroblastoma

13:40 – 14:10 Katleen de Preter (Ghent): Improved diagnosis and risk stratification of paediatric cancers using liquid biopsies

14:10 – 14:25 Sue Burchill (Leeds): Self-renewing neuroblastoma cells isolated from bone marrow aspirates of children with stage M disease share a mesenchymal expression signature: an NCRI CCL CSG Neuroblastoma Group Study

14:25 – 14:40 Combined discussion

14:40 – 15:30 Tea with Posters

Session 2: Targeted & combination therapy I

Cancer Research UK Cambridge Centre Neuro-oncology Programme Session

15:30 – 16:00 Rogier Versteeg (Amsterdam): The dark side of neuroblastoma

16:00 – 16:15 Melinda Halasz (University College Dublin): Anti-Cancer Effects of Diphenyleneiodonium Chloride (DPI) In MYCN-Amplified Neuroblastoma

16:15 – 16:45 Thomas Look (Harvard): Neuroblastoma: MYCN and MYC commandeer core transcriptional circuitry to create dependencies with therapeutic implication

16:45 – 17:00 Combined discussion

Downing College - Main Hall.jpg

17:00 – 18:45 Poster viewing & Drinks

19:15  Symposium Dinner at Downing College

Friday 12th April

08:30 – 08:50 Coffee

Session 3: Neural crest & differentiation therapy I

08:50 – 09:20 Igor Adameyko (Karolinska): Normal development of sympathoadrenal system resolved with lineage tracing and single cell transcriptomics

09:20 – 09:35 Anestis Tsakiridis (Sheffield): Efficient generation of trunk neural crest and sympathetic neurons from human pluripotent stem cells via a neuromesodermal progenitor intermediate

09:35 – 10:05 Quenten Schwarz (Adelaide): Guiding sympathoadrenal neural crest cells to the adrenal primordia

10:05 – 10:20 Combined discussion

10:20 – 10:50 Coffee with Posters

Session 4: Neural crest & differentiation therapy II

10:50 – 11:20 Karen Liu (King’s College London): ALK and GSK3 - shared features of neuroblastoma and neural crest

11:20 – 11:50 Anna Philpott (Cambridge): Using developmental mechanisms to drive differentiation of neuroblastoma

11:50 – 12:05 Evon Poon (ICR, Sutton): Pharmacological blockade of high-risk MYCN driven neuroblastoma using an orally-bioavailable CDK2/9 inhibitor

12:05 – 12:20 Combined discussion

12:20 – 13:20 Lunch with Posters

Session 5: Targeted & combination therapy II

13:20 – 13:50 Cancer Research UK Cambridge Centre Paediatrics Programme Lecture

Sharon Diskin (Philadelphia): DLK1 as a new immunotherapeutic target

13:50 – 14:05 Miriam Rosenberg (Jerusalem): Expression- and immune-profiling of neuroblastoma-associated Opsoclonus Myoclonus Ataxia Syndrome (OMAS) to identify features of auto- and tumour-immunity

14:05 – 14:35 Suzanne Turner (Cambridge): CRISPR-dCas9 screens to identify resistance mechanisms to ALK in neuroblastoma

14:35 – 14:50 Combined discussion

14:50 – 15:20 Tea with Posters

Session 6: Targeted & combination therapy III

15:20 15:35 Sally George (ICR, Sutton): A CRISPR-Cas9 genomic editing and compound screening approach identifies therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma

15:35 – 16:05 Per Kogner (Karolinska): The PPM1D encoded WIP1 phosphatase is an oncogene significant for cancer development and tumour progression and a druggable therapy target in neuroblastoma and medulloblastoma. A hint as to how aggressive childhood cancer manages with wild-type p53

16:05 – 16:20 Deb Tweddle (Newcastle): Preclinical assessment of MDM2/p53, ALK and MEK inhibitor combinations in neuroblastoma

16:20 – 16:35 Donne Nile (Glasgow): Manipulation of cancer cell metabolism for neuroblastoma combination therapy with targeted radiotherapy

16:35 – 16:50 Combined discussion

16:50 Poster prizes

17:00 Close

View Event →

The Vitality British 10k London Run
9:30 AM09:30

The Vitality British 10k London Run

Run this great event for Neuroblastoma UK! Places are still available if you book directly with us - the route proves hugely popular with both new and seasoned runners, attracted by the chance to run one of the most unique routes in the world and be spurred on by tens of thousands of spectators lining the route from start to finish.

View Event →
Advances in Neuroblastoma Research - Parents’ Day Webinar
1:00 PM13:00

Advances in Neuroblastoma Research - Parents’ Day Webinar

As part of the 2016 Advances in Neuroblastoma Research (ANR) conference, ANR is hosting for the first time a Parent’s Day in Cairns on 24 June where you can attend interactive sessions led by a unique team of international research  and clinical experts to learn about the latest advances in research  and clinical care for neuroblastoma.

View Event →
Brighton Marathon 2016
7:30 PM19:30

Brighton Marathon 2016

We invite applications from individuals and teams for this marathon. We ask for a £25 registration fee and a commitment to raise £300 in sponsorship. We often find people who are unable to get places in the London Marathon enter this marathon.  Some even enter both!

View Event →
3rd Neuroblastoma Research Symposium, 2013
to Nov 7

3rd Neuroblastoma Research Symposium, 2013

The 3rd Neuroblastoma Research Symposium was held on 6-7 November 2013 at the BT Convention Centre, Kings Dock, Liverpool as a satellite meeting of the 2013 NCRI Conference. The programme contained sessions on: the role of MYC in childhood cancers; genetic landscape of Neuroblastoma; advances in differentiation therapy; mouse models; tumour biology and evolution; and a plenary Oral Poster Presentation session presented by up-and-coming researchers.

View Event →
2nd Neuroblastoma Research Symposium, 2011
7:30 PM19:30

2nd Neuroblastoma Research Symposium, 2011

The 2nd Neuroblastoma Research Symposium was held on Friday, 14th October 2011 at the Institute of Child Health, London,in collaboration with SIOPEN (International Society of Paediatric Oncology European Neuroblastoma) and the UK CCLG (Children’s Cancer and Leukaemia Group).Invited international speakers spoke in three themed sessions: on immunotherapy; gene and micro-RNA signatures of Neuroblastoma; and new treatments. In addition there were shorter talks chosen from submitted talk abstracts and a poster session.

View Event →